Pricing Log in Create free account

Atara Biotherapeutics, Inc. (ATRA) vs PMV Pharmaceuticals, Inc. (PMVP)

Atara Biotherapeutics, Inc. and PMV Pharmaceuticals, Inc. are both Biotechnology companies. Atara Biotherapeutics, Inc. and PMV Pharmaceuticals, Inc. are of similar size ($97.4M and $96.9M). PMV Pharmaceuticals, Inc. has the higher net margin (0.00% vs −269.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Atara Biotherapeutics, Inc. leads on 7 and PMV Pharmaceuticals, Inc. on 4.

Valuation

Metric ATRA PMVP Biotechnology median
P/E n/m n/m 8.50
P/S 22.28 n/m 9.71
P/B n/m 0.90 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.18 0.64
EV/Sales 20.69 n/m 9.21
Earnings yield (12.85%) (117.36%) (33.15%)
Free cash flow yield (15.24%) (110.32%) (25.50%)

Profitability

Metric ATRA PMVP Biotechnology median
Gross margin 91.38% 0.00% 65.16%
Operating margin (229.67%) 0.00% 0.00%
Net margin (269.42%) 0.00% 0.00%
Free cash flow margin (353.49%) 0.00% 0.00%
Return on equity 46.33% (70.93%) (56.36%)
Return on assets (57.62%) (64.04%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATRA PMVP Biotechnology median
Revenue growth (TTM) (96.72%) — 6.02%
EPS growth (last fiscal year) 122.52% (29.82%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATRA PMVP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.98 7.70 4.72
Net debt to EBITDA (0.22) 1.27 0.96

Dividend

Metric ATRA PMVP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ATRA PMVP Biotechnology median
Market cap 96.86m 97.42m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack